Submitted by admin on September 13, 2024 - 11:25am
Neurocrine's bid to save schizophrenia prospect fails
ESMO: Moderna’s mRNA solid tumour vaccine shows early promise
FDA approves Roche’s Tecentriq Hybreza for cancer
Three biotechs raise $700M in rare burst of IPO activity
*please scroll down for all the latest news*
